Chapter 6. Antimicrotubule Agents

  1. Sotiris Missailidis
  1. Iain Brown,
  2. Jay N. Sangrithi-Wallace and
  3. Andrew C. Schofield

Published Online: 7 NOV 2008

DOI: 10.1002/9780470697047.ch6

Anticancer Therapeutics

Anticancer Therapeutics

How to Cite

Brown, I., Sangrithi-Wallace, J. N. and Schofield, A. C. (2008) Antimicrotubule Agents, in Anticancer Therapeutics (ed S. Missailidis), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470697047.ch6

Editor Information

  1. Department of Chemistry and Analytical Sciences, The Open University, Milton Keynes, UK

Author Information

  1. School of Medicine, College of Life Sciences and Medicine, University of Aberdeen, Aberdeen, UK

Publication History

  1. Published Online: 7 NOV 2008
  2. Published Print: 21 NOV 2008

ISBN Information

Print ISBN: 9780470723036

Online ISBN: 9780470697047



  • taxanes and antitumour properties;
  • antimicrotubule agents;
  • taxane side effects;
  • Vinca alkaloids - antimicrotubule agents;
  • Vinca alkaloids and vinca-binding domain;
  • Vindesine and acute lymphocytic leukaemia treatment;
  • pathway resistance - multiple mechanisms


This chapter contains sections titled:

  • Taxanes

  • Vinca Alkaloids

  • Mechanisms of Resistance to Antimicrotubule Agents

  • References